InsidersTradesSigma
基于 8 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Ben Arye Barak. Director active across 1 company, notably NovoCure Ltd. In total, 12 reports have been logged. History available since 5 July 2022. The latest transaction was disclosed on 3 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Ben Arye Barak is General Counsel at NovoCure Ltd. The declarant has 9 filings in total, and the 9 sampled filings, all of Attribution nature, run from 2022-07-07 to 2026-07-01. Buy and sell volumes in this sample are EUR 0 and EUR 0, and the largest filings include EUR 953735.4957277525 on 2025-03-06, EUR 10630.08730410319 on 2024-08-06, EUR 9481.324115343326 on 2025-01-03, EUR 9349.109617087815 on 2023-07-06, EUR 8881.92035325642 on 2023-01-10, and EUR 8293.108760081632 on 2022-07-07.